Literature DB >> 28445874

Erythropoietin Treatment Exacerbates Moderate Injury after Hypoxia-Ischemia in Neonatal Superoxide Dismutase Transgenic Mice.

R Ann Sheldon1, Christine Windsor, Byong Sop Lee, Olatz Arteaga Cabeza, Donna M Ferriero.   

Abstract

The neonatal brain is highly susceptible to oxidative stress as developing endogenous antioxidant mechanisms are overwhelmed. In the neonate, superoxide dismutase (SOD) overexpression worsens hypoxic-ischemic injury due to H2O2 accumulation in the brain. Erythropoietin (EPO) is upregulated in 2 phases after HI, early (4 h) and late (7 days), and exogenous EPO has been effective in reducing the injury, possibly through reducing oxidative stress. We hypothesized that exogenous EPO would limit injury from excess H2O2 seen in SOD1-overexpressing mice, and thus enhance recovery after HI. We first wanted to confirm our previous findings in postnatal day 7 (P7) SOD-tg (CD1) mice using a P9 model of the Vannucci procedure of HI with SOD-tg mice from a different background strain (C57Bl/6), and then determine the efficacy of EPO treatment in this strain and their wild-type (WT) littermates. Thus, mice overexpressing copper/zinc SOD1 were subjected to HI, modified for the P9 mouse, and recombinant EPO (5 U/g) or vehicle (saline) was administered intraperitoneally 3 times: at 0 h, 24 h, and 5 days. Injury was assessed 7 days after HI. In addition, protein expression for EPO and EPO receptor was assessed in the cortex and hippocampus 24 h after HI. With the moderate insult, the SOD-tg mice had greater injury than the WT overall, confirming our previous results, as did the hippocampus and striatum when analyzed separately, but not the cortex or thalamus. EPO treatment worsened injury in SOD-tg overall and in the WT and SOD-tg hippocampus and striatum. With the more severe insult, all groups had greater injury than with the moderate insult, but differences between SOD-tg and WT were no longer observed and EPO treatment had no effect. Increased protein expression of EPO was observed in the cortex of SOD-tg mice given recombinant human EPO compared to SOD-tg given vehicle. This study confirms our previous results showing greater injury with SOD overexpression in the neonatal brain after HI at P7 in a different strain. These results also suggest that EPO treatment cannot ameliorate the damage seen in situations where there is excess H2O2 accumulation, and it may exacerbate injury in settings of extreme oxidative stress.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Brain injury; Erythropoietin; Hypoxia-ischemia; Mouse; Superoxide-dismutase

Mesh:

Substances:

Year:  2017        PMID: 28445874      PMCID: PMC5972513          DOI: 10.1159/000472710

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  38 in total

1.  High-Dose Erythropoietin and Hypothermia for Hypoxic-Ischemic Encephalopathy: A Phase II Trial.

Authors:  Yvonne W Wu; Amit M Mathur; Taeun Chang; Robert C McKinstry; Sarah B Mulkey; Dennis E Mayock; Krisa P Van Meurs; Elizabeth E Rogers; Fernando F Gonzalez; Bryan A Comstock; Sandra E Juul; Michael E Msall; Sonia L Bonifacio; Hannah C Glass; An N Massaro; Lawrence Dong; Katherine W Tan; Patrick J Heagerty; Roberta A Ballard
Journal:  Pediatrics       Date:  2016-05-02       Impact factor: 7.124

2.  Beneficial effect of erythropoietin on sensorimotor function and white matter after hypoxia-ischemia in neonatal mice.

Authors:  Xiyong Fan; Cobi J Heijnen; Michael A van der KOOIJ; Floris Groenendaal; Frank van Bel
Journal:  Pediatr Res       Date:  2011-01       Impact factor: 3.756

3.  Erythropoietin increases glutathione peroxidase enzyme activity and decreases lipid peroxidation levels in hypoxic-ischemic brain injury in neonatal rats.

Authors:  Abdullah Kumral; Sevil Gonenc; Osman Acikgoz; Atac Sonmez; Kursad Genc; Osman Yilmaz; Necati Gokmen; Nuray Duman; Hasan Ozkan
Journal:  Biol Neonate       Date:  2004-08-27

4.  Erythropoietin exerts neuroprotective effect in neonatal rat model of hypoxic-ischemic brain injury.

Authors:  Adem Aydin; Kursad Genç; Mustafa Akhisaroglu; Kutsal Yorukoglu; Necati Gokmen; Erdem Gonullu
Journal:  Brain Dev       Date:  2003-10       Impact factor: 1.961

5.  Brain injury after perinatal hypoxia-ischemia is exacerbated in copper/zinc superoxide dismutase transgenic mice.

Authors:  J S Ditelberg; R A Sheldon; C J Epstein; D M Ferriero
Journal:  Pediatr Res       Date:  1996-02       Impact factor: 3.756

6.  Concurrent erythropoietin and hypothermia treatment improve outcomes in a term nonhuman primate model of perinatal asphyxia.

Authors:  Christopher M Traudt; Ronald J McPherson; Larry A Bauer; Todd L Richards; Thomas M Burbacher; Ryan M McAdams; Sandra E Juul
Journal:  Dev Neurosci       Date:  2013-11-01       Impact factor: 2.984

7.  Effect of Early Prophylactic High-Dose Recombinant Human Erythropoietin in Very Preterm Infants on Neurodevelopmental Outcome at 2 Years: A Randomized Clinical Trial.

Authors:  Giancarlo Natalucci; Beatrice Latal; Brigitte Koller; Christoph Rüegger; Beate Sick; Leonhard Held; Hans Ulrich Bucher; Jean-Claude Fauchère
Journal:  JAMA       Date:  2016-05-17       Impact factor: 56.272

8.  Strain-related brain injury in neonatal mice subjected to hypoxia-ischemia.

Authors:  R A Sheldon; C Sedik; D M Ferriero
Journal:  Brain Res       Date:  1998-11-09       Impact factor: 3.252

9.  Overproduction of human Cu/Zn-superoxide dismutase in transfected cells: extenuation of paraquat-mediated cytotoxicity and enhancement of lipid peroxidation.

Authors:  O Elroy-Stein; Y Bernstein; Y Groner
Journal:  EMBO J       Date:  1986-03       Impact factor: 11.598

10.  Erythropoietin Ameliorates Neonatal Hypoxia-Ischemia-Induced Neurobehavioral Deficits, Neuroinflammation, and Hippocampal Injury in the Juvenile Rat.

Authors:  Kuo-Mao Lan; Lu-Tai Tien; Zhengwei Cai; Shuying Lin; Yi Pang; Sachiko Tanaka; Philip G Rhodes; Abhay J Bhatt; Renate D Savich; Lir-Wan Fan
Journal:  Int J Mol Sci       Date:  2016-02-26       Impact factor: 5.923

View more
  7 in total

1.  Strain-Related Differences in Mouse Neonatal Hypoxia-Ischemia.

Authors:  R Ann Sheldon; Christine Windsor; Donna M Ferriero
Journal:  Dev Neurosci       Date:  2019-02-28       Impact factor: 2.984

2.  Protective Effects of Intranasally Administrated Oxytocin-Loaded Nanoparticles on Pentylenetetrazole-Kindling Epilepsy in Terms of Seizure Severity, Memory, Neurogenesis, and Neuronal Damage.

Authors:  Hakan Sahin; Oguz Yucel; Serkan Emik; Gozde Erkanli Senturk
Journal:  ACS Chem Neurosci       Date:  2022-06-17       Impact factor: 5.780

Review 3.  Oxidative stress and endoplasmic reticulum (ER) stress in the development of neonatal hypoxic-ischaemic brain injury.

Authors:  Claire Thornton; Ana A Baburamani; Anton Kichev; Henrik Hagberg
Journal:  Biochem Soc Trans       Date:  2017-09-22       Impact factor: 5.407

Review 4.  Can Erythropoietin Reduce Hypoxemic Neurological Damages in Neonates With Congenital Heart Defects?

Authors:  Sara Ottolenghi; Giuseppina Milano; Michele Dei Cas; Tina O Findley; Rita Paroni; Antonio F Corno
Journal:  Front Pharmacol       Date:  2021-11-29       Impact factor: 5.810

Review 5.  The Effect of Erythropoietin and Its Derivatives on Ischemic Stroke Therapy: A Comprehensive Review.

Authors:  Yuanyuan Ma; Zhiyuan Zhou; Guo-Yuan Yang; Jing Ding; Xin Wang
Journal:  Front Pharmacol       Date:  2022-02-17       Impact factor: 5.810

6.  Neuroprotective effects of a dendrimer-based glutamate carboxypeptidase inhibitor on superoxide dismutase transgenic mice after neonatal hypoxic-ischemic brain injury.

Authors:  O Arteaga Cabeza; Z Zhang; E Smith Khoury; R A Sheldon; A Sharma; F Zhang; B S Slusher; R M Kannan; S Kannan; D M Ferriero
Journal:  Neurobiol Dis       Date:  2020-11-30       Impact factor: 5.996

Review 7.  Recent advances in perinatal neuroprotection.

Authors:  Samata Singhi; Michael Johnston
Journal:  F1000Res       Date:  2019-11-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.